Afraxis Inc.

About

Afraxis Inc. is a contract research organization (CRO) specializing in: CNS preclinical efficacy evaluations (in vivo & in vitro) Neurotoxicity evaluations Structure-Efficacy Relationship (SER)-driven medicinal chemistry Afraxis' patented ESP (Enhanced Spine Profiling) technology produces rapid, high-information read-outs of synaptic networks from in-vivo/in-vitro/ex-vivo preparations. The ESP process incorporates specialized labeling of individual neurons; high-resolution imaging; rapid high-detail morphometry of individual cells, processes, and synapses; and powerful statistical methods and analytical displays tailored for efficient interpretation of large data sets.